Rydapt receives NICE recomendation to treat agressive systemic mastocytosis – Novartis
Novartis welcomed the news that the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination recommending Rydapt (midostaurin) for the treatment of aggressive… read more.